mesalamine and oxazolone

mesalamine has been researched along with oxazolone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ekström, GM1
Hatakeyama, S; Kojima, R; Kuroda, S; Nakamaru, K; Ohkishi, T1
Cui, YL; Ding, TT; Yang, X; Zhang, HQ; Zhang, HX; Zhang, JJ; Zhao, JS1
Li, YS; Tao, YW; Wang, H; Zhang, JY; Zhang, ZQ; Zhou, Y1
Chen, M; Chen, W; Huang, ZH; Ouyang, Q; Xue, LY; Yu, LM; Zhou, XG1
Abu-Risha, SE; El-Kadem, AH; El-Mahdy, NA; El-Sayad, ME1
Caviglia, GP; Ribaldone, DG; Vernero, M1

Other Studies

7 other study(ies) available for mesalamine and oxazolone

ArticleYear
Oxazolone-induced colitis in rats: effects of budesonide, cyclosporin A, and 5-aminosalicylic acid.
    Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:2

    Topics: Animals; Budesonide; Colitis; Colon; Cyclosporine; Disease Models, Animal; Female; Intestinal Mucosa; Mesalamine; Organ Size; Oxazolone; Peroxidase; Rats; Time Factors

1998
Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis.
    Journal of pharmacological sciences, 2004, Volume: 96, Issue:3

    Topics: Animals; Colitis; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Mesalamine; Mice; Mice, Inbred BALB C; Oxazolone; Prednisolone

2004
Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats.
    World journal of gastroenterology, 2009, Apr-21, Volume: 15, Issue:15

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Calcitonin Gene-Related Peptide; Clostridium butyricum; Colitis; Colon; Disease Models, Animal; Feces; Interleukin-23; Mesalamine; Organ Size; Oxazolone; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha

2009
[Paeoniflorin increases beta-defensin expression and attenuates lesion in the colonic mucosa from mice with oxazolone-induced colitis].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; beta-Defensins; Bridged-Ring Compounds; Colitis; Colon; Female; Glucosides; Interleukin-10; Interleukin-6; Intestinal Mucosa; Mesalamine; Mice; Mice, Inbred BALB C; Monoterpenes; Oxazolone; Paeonia; Random Allocation; RNA, Messenger

2010
Bacterial immune interaction in experimental colitis.
    Journal of digestive diseases, 2013, Volume: 14, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Colitis, Ulcerative; Colon; Disease Models, Animal; Female; Intestinal Mucosa; Mesalamine; Mice; Mice, Inbred BALB C; Microbiota; Occludin; Oxazolone; Polymorphism, Restriction Fragment Length; Severity of Illness Index; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2013
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
    Fundamental & clinical pharmacology, 2021, Volume: 35, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Colitis, Ulcerative; Colon; Drug Therapy, Combination; Interleukin-10; Interleukin-13; Interleukin-6; Male; Mesalamine; Oxazolone; Rats; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein

2021
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis.
    Fundamental & clinical pharmacology, 2021, Volume: 35, Issue:1

    Topics: Anti-Inflammatory Agents; Atorvastatin; Colitis; Gene Expression; Humans; Interleukin-10; Interleukin-6; Mesalamine; Oxazolone

2021